1 |
Mahmud N, Chapin SE, Kaplan DE, Serper M. Identifying Patients at Highest Risk of Remaining Unvaccinated Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Large Veterans Health Administration Cohort. Liver Transpl 2021. [PMID: 34293247 DOI: 10.1002/lt.26235] [Reference Citation Analysis]
|
2 |
Goldberg D, Mantero A, Kaplan D, Delgado C, John B, Nuchovich N, Emanuel E, Reese PP. Accurate long-term prediction of death for patients with cirrhosis. Hepatology 2022. [PMID: 35278226 DOI: 10.1002/hep.32457] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Su F. COVID-19 and Cirrhosis: A Combination We Must Strive to Prevent. Gastroenterology 2021;161:1371-3. [PMID: 34453892 DOI: 10.1053/j.gastro.2021.08.037] [Reference Citation Analysis]
|
4 |
Gato S, Lucena-Valera A, Muñoz-Hernández R, Sousa JM, Romero-Gómez M, Ampuero J. Impact of COVID-19 on liver disease: From the experimental to the clinic perspective. World J Virol 2021; 10(6): 301-311 [PMID: 34909404 DOI: 10.5501/wjv.v10.i6.301] [Reference Citation Analysis]
|
5 |
Iavarone M, Antonelli B, Ierardi AM, Topa M, Sangiovanni A, Gori A, Oggioni C, Rossi G, Carrafiello G, Lampertico P. Reshape and secure HCC managing during COVID-19 pandemic: A single centre analysis of four periods in 2020 versus 2019. Liver Int 2021. [PMID: 34614270 DOI: 10.1111/liv.15077] [Reference Citation Analysis]
|
6 |
Tapper EB, Parikh ND. The Future of Quality Improvement for Cirrhosis. Liver Transpl 2021. [PMID: 33887806 DOI: 10.1002/lt.26079] [Reference Citation Analysis]
|